<code id='EECA9D3F33'></code><style id='EECA9D3F33'></style>
    • <acronym id='EECA9D3F33'></acronym>
      <center id='EECA9D3F33'><center id='EECA9D3F33'><tfoot id='EECA9D3F33'></tfoot></center><abbr id='EECA9D3F33'><dir id='EECA9D3F33'><tfoot id='EECA9D3F33'></tfoot><noframes id='EECA9D3F33'>

    • <optgroup id='EECA9D3F33'><strike id='EECA9D3F33'><sup id='EECA9D3F33'></sup></strike><code id='EECA9D3F33'></code></optgroup>
        1. <b id='EECA9D3F33'><label id='EECA9D3F33'><select id='EECA9D3F33'><dt id='EECA9D3F33'><span id='EECA9D3F33'></span></dt></select></label></b><u id='EECA9D3F33'></u>
          <i id='EECA9D3F33'><strike id='EECA9D3F33'><tt id='EECA9D3F33'><pre id='EECA9D3F33'></pre></tt></strike></i>

          Home / comprehensive / knowledge

          knowledge


          knowledge

          author:fashion    Page View:49
          Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

          In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

          The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks. 

          advertisement

          “Oh, crap,” Secrist said to herself.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In